Oncothyreon is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. We are currently developing multiple therapeutic candidates designed to target cancer in specific and effective ways. Our pipeline includes both synthetic vaccines and small molecules for a variety of cancer indications.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oncothyreon.com
Oncothyreon, Inc. Questions
Oncothyreon, Inc.'s website is oncothyreon.com
Oncothyreon, Inc.'s LinkedIn profile is https://www.linkedin.com/company/oncothyreon-inc.
Oncothyreon, Inc.'s industry is
Biotechnology Research
Oncothyreon, Inc.'s top competitors are
Regenxbio,
Neuraly Inc.,
Helix Biomedix,
Astrazeneca,
Lsbio | Lifespan Biosciences, Inc.,
Washington Global Health Alliance,
Sangamo Therapeutics, Inc.,
Amnis Corporation,
Metrodora Therapeutics, Inc.,
Cascadian Therapeutics, Inc..
Oncothyreon, Inc.'s categories are Biotechnology Research
